Insulin resistance as a major determinant of increased coronary heart disease risk in postmenopausal women with type 2 diabetes mellitus

Diabetic Medicine

Volumn 18, Issue 6, 2001, Pages 476-482

  Stoney, R M ^a   O'Dea, K ^b   Herbert, K E ^c   Dragicevic, G ^c   Giles, G G ^d   Cumpston, G N ^e   Best, James D ^c  

^a ALFRED HOSPITAL   (Australia)

^b MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d CANCER EPIDEMIOLOGY CENTRE   (Australia)

^e ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Coronary heart disease; Insulin resistance; Plasminogen activator inhibitor 1; Postmenopausal women; Type 2 diabetes mellitus

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; LOW DENSITY LIPOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY COMPOSITION; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DYSLIPIDEMIA; ELECTROCARDIOGRAM; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; ISCHEMIC HEART DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTMENOPAUSE; SYSTOLIC BLOOD PRESSURE;

ADIPOSE TISSUE; AGED; ALBUMINURIA; BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL; CORONARY DISEASE; DENSITOMETRY, X-RAY; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; ELECTROCARDIOGRAPHY; FACTOR VII; FEMALE; FIBRINOGEN; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; LIPOPROTEINS; LIPOPROTEINS, LDL; MIDDLE AGED; MODELS, BIOLOGICAL; PLASMINOGEN ACTIVATOR INHIBITOR 1; POSTMENOPAUSE; PROINSULIN; RISK FACTORS; TRIGLYCERIDES;

EID: 0034897070     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2001.00504.x     Document Type: Article

References (27)

1. The impact of gender and general risk factors on the occurrence of atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus
2. The impact of diabetes on survival following myocardial infarction in women vs men
3. Sex differences in the impact of coexistent diabetes on survival in patients with coronary heart disease
4. Pathogenesis of NIDDM. A balanced overview
5. Insulin sensitivity and atherosclerosis
6. Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: The Insulin Resistance Atherosclerosis Study
7. Evidence of higher insulin resistance in NIDDM patients with ischaemic heart disease
8. The Melbourne study of diet and cancer
9. Body fat distribution and non-insulin-dependent diabetes: Comparison of a fiber-rich, high-carbohydrate, low-fat (23%) diet and a 35% fat diet high in monounsaturated fat
10. Estimating intraabdominal adipose tissue in women by dual-energy x-ray absorptiometry
11. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man
12. Identification of multiple subclasses of plasma low density lipoproteins in normal humans
13. A new method for the determination of fibrinogen in small samples of plasma
14. The prevalence of coronary heart disease and associated factors in an Australian rural community
15. Self-administration of a questionnaire on chest pain and intermittent claudication
16. Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients
17. Optimization of glycemic control by insulin therapy decreases the proportion of small dense LDL particles in diabetic patients
18. Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction
19. Triacylglycerol and coronary heart disease
20. Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride and insulin concentrations
21. Determinants of plasminogen activator inhibitor 1 activity in treated NIDDM and its relation to a polymorphism in the plasminogen activator inhibitor 1 gene
22. Endothelial dysfunction: Cause of the insulin resistance syndrome
23. PAI-1, obesity, insulin resistance and risk of cardiovascular events
24. Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: A potential factor predisposing to thrombosis and its persistence
25. Improved glycemic control and lipid profile and normalized fibrinolyic activity on a low-glycemic index diet in type 2 diabetic patients